Cost-effectiveness of trilaciclib for preventing myelosuppression from E/P-containing chemotherapy in extensive-stage small-cell lung cancer

LIU Ranjia, ZHEN Xuebing, QIU Tingting, WU Yi, WANG Yuting, WANG Zhenhuan, LYU Xinge, CUI Xiangli

Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (1) : 58-63.

PDF(927 KB)
PDF(927 KB)
Chinese Journal of Hospital Pharmacy ›› 2026, Vol. 46 ›› Issue (1) : 58-63. DOI: 10.13286/j.1001-5213.2026.01.09
Drug and Clinical Practice

Cost-effectiveness of trilaciclib for preventing myelosuppression from E/P-containing chemotherapy in extensive-stage small-cell lung cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2026, 46(1): 58-63 https://doi.org/10.13286/j.1001-5213.2026.01.09

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(927 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉